The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A prospective trial for defining a subset of patients with limited metastatic gastric cancer who may be candidates for bimodal treatment strategies: FLOT3.
Salah-Eddin Al-Batran
No relevant relationships to disclose
Ralf Hofheinz
No relevant relationships to disclose
Nils Homann
No relevant relationships to disclose
Gerald Illerhaus
No relevant relationships to disclose
Uwe Marc Martens
No relevant relationships to disclose
Jan Stoehlmacher-Williams
No relevant relationships to disclose
Harald Schmalenberg
No relevant relationships to disclose
Kim Barbara Luley
No relevant relationships to disclose
Nicole Prasnikar
No relevant relationships to disclose
Matthias Egger
No relevant relationships to disclose
Stephan Probst
No relevant relationships to disclose
Joerg Thomas Hartmann
No relevant relationships to disclose
Markus Hermann Moehler
No relevant relationships to disclose
Dirk Arnold
No relevant relationships to disclose
Wolfgang Fischbach
No relevant relationships to disclose
Claudia Pauligk
No relevant relationships to disclose
Wael Hozaeel
No relevant relationships to disclose
Stefan Paul Moenig
No relevant relationships to disclose
Arnulf H Hölscher
No relevant relationships to disclose
Elke Jäger
No relevant relationships to disclose